New Drugs and Novel Cellular Targets against Tuberculosis

New Drugs and Novel Cellular Targets against Tuberculosis

<i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) is the etiological agent of tuberculosis (TB), one of the most life-threatening communicable diseases, which causes 10 million new cases each year and results in an estimated 1 [...]

Bibliographic Details
Main Authors:	Giulia Degiacomi, Vadim Makarov, Maria Rosalia Pasca, Laurent Roberto Chiarelli
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	International Journal of Molecular Sciences
Subjects:	n/a
Online Access:	https://www.mdpi.com/1422-0067/23/22/13680

Similar Items

Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01)

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
by: Elena G. Salina, et al.
Published: (2022-12-01)

Editorial on Special Issue “Tuberculosis Drug Discovery and Development 2019”
by: Claudia Sala, et al.
Published: (2020-09-01)

Editorial: New Approaches Against Drug-Resistant M. tuberculosis
by: Yossef Av-Gay, et al.
Published: (2021-04-01)

Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
by: Giorgia Mori, et al.
Published: (2020-02-01)

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
by: Giulia Degiacomi, et al.
Published: (2020-09-01)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the <i>Mycobacterium tuberculosis</i> DprE1 Enzyme
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2022-01-01)

The Antimalarial Mefloquine Shows Activity against <i>Mycobacterium abscessus</i>, Inhibiting Mycolic Acid Metabolism
by: Giulia Degiacomi, et al.
Published: (2021-08-01)

<i>Mycobacterium abscessus</i> Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
by: Deborah Recchia, et al.
Published: (2023-02-01)

Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
by: Simon J. Allison
Published: (2022-07-01)

Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
by: Laurent R. Chiarelli, et al.
Published: (2020-04-01)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
by: Donatella Tondi
Published: (2021-02-01)

New Sight: Enzymes as Targets for Drug Development
by: Sung-Kun Kim
Published: (2023-09-01)

Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections.
by: Aygun Israyilova, et al.
Published: (2016-01-01)

Drugs and Vaccines Will Be Necessary to Control Tuberculosis
by: Rino Rappuoli
Published: (2020-06-01)

Cellular and Molecular Targets in Acute Ischemic Stroke
by: Peter Kraft, et al.
Published: (2022-09-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
by: Michael Gütschow, et al.
Published: (2020-06-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–2
by: Diego Muñoz-Torrero, et al.
Published: (2017-12-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
by: Jean Jacques Vanden Eynde, et al.
Published: (2019-12-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3
by: Arduino A. Mangoni, et al.
Published: (2018-06-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–4
by: Arduino A Mangoni, et al.
Published: (2018-12-01)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–5
by: Arduino A. Mangoni, et al.
Published: (2019-06-01)

Molecular Mechanisms to Target Cellular Senescence in Aging and Disease
by: Serena Marcozzi, et al.
Published: (2022-11-01)

New Hopes for Drugs against COVID-19 Come from the Sea
by: Orazio Taglialatela-Scafati
Published: (2021-02-01)

Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II
by: Andrzej Kutner, et al.
Published: (2023-03-01)

Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume I
by: Andrzej Kutner, et al.
Published: (2022-06-01)

Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials
by: Dmitry Aminin
Published: (2023-05-01)

Novel Approaches for the Delivery of Anti-HIV Drugs—What Is New?
by: José das Neves
Published: (2019-10-01)

In Silico Novel Drug Design Targeting the Oral Microbiome: Endodontic and Periodontal Pathogenic Bacteria
by: Maurilio D’Angelo, et al.
Published: (2021-11-01)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
by: Roberto Bei, et al.
Published: (2023-04-01)

Stem and Cancer Stem Cell Identities, Cellular Markers, Niche Environment and Response to Treatments to Unravel New Therapeutic Targets
by: Jose R. Pineda, et al.
Published: (2021-01-01)

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”
by: Carlos Martínez-Campa, et al.
Published: (2020-06-01)

Protein-Targeting Drug Discovery
by: Caterina Vicidomini, et al.
Published: (2023-10-01)

Nanotechnology in Targeted Drug Delivery
by: Antonio Di Stefano
Published: (2023-05-01)

Brain-Targeted Drug Delivery
by: Flávia Sousa
Published: (2022-08-01)

Mitochondria-Targeted Drug Delivery
by: Joanna Kopecka
Published: (2022-01-01)

Special Issue “Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions”
by: Okhil K. Nag, et al.
Published: (2023-09-01)

Starting Editorial of “Cellular Damage: Protection and Induction” Addressing Hot Topics in Cellular Damage, Protection of Cells and Therapy Targeting Bad Cells
by: Songwen Tan, et al.
Published: (2023-09-01)

Advances in Mitochondria-Targeted Drug Delivery
by: Emanuela Bottani, et al.
Published: (2023-08-01)

Enzymes as Targets for Drug Development II
by: Sung-Kun Kim
Published: (2023-02-01)